Tetrahydroquinoline and tetrahydroisoquinoline mixed ligand rhenium complexes with the SNS/S donor atom set

Applied Organometallic Chemistry

Volumn 21, Issue 4, 2007, Pages 288-293

  Zablotskaya, Alla ^a   Segal, Izolda ^a   Lukevics, Edmunds ^a   Belyakov, Sergey ^a   Spies, Hartmut ^b  

^a LATVIAN INSTITUTE OF ORGANIC SYNTHESIS   (Latvia)

^b INSTITUTE OF ION BEAM PHYSICS AND MATERIALS RESEARCH   (Germany)

Author keywords

Cytotoxicity; Metal based drugs; Mixed ligand oxorhenium complexes; Molecular structure; Psychotropic activity; Rhenium; Tetrahydroisoquinoline; Tetrahydroquinoline

Indexed keywords

CYTOTOXICITY; DERIVATIVES; LIGANDS; METAL COMPLEXES; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SULFUR COMPOUNDS; SYNTHESIS (CHEMICAL);

METAL BASED DRUGS; MIXED LIGAND OXORHENIUM COMPLEXES; PSYCHOTROPIC ACTIVITY; TETRAHYDROISOQUINOLINE; TETRAHYDROQUINOLINE; THIOLS;

RHENIUM COMPOUNDS;

EID: 33947517230     PISSN: 02682605     EISSN: 10990739     Source Type: Journal    
DOI: 10.1002/aoc.1201     Document Type: Article

References (26)

1. Fietz Th, Spies H, Zablotskaya A, Scheller D. Inst. Bioanorg. Radiopharm. Chem., FZ-Rossendorf, Annual Report 1997; 113.
2. Spies H, Fietz Th, Zablotskaya A, Belyakov S, Lukevics E. Chem. Heterocycl. Compd 1999; 35: 112.
3. Zablotskaya A, Segal I, Kemme A, Germane S, Popelis J, Lukevics E, Berger R, Spies H. Chem. Heterocycl. Compd 2002; 38: 477.
4. Kniess T, Spies H, Santos I, Zablotskaya A. J. Label. Compd Radiopharm. 2002; 45: 629.
5. Heier RF, Dolak LA, Duncan JN, Hyslop DK, Lipton MF, Martin IJ, Mauragis MA, Piercey MF, Nichols NF, Schreur PJKD, Smith MW, Moon MW. J. Med. Chem. 1997; 40: 639.
6. Mokrosz MJ, Bojarski AJ, Duszynska B, Tatarczynska E, Klodzinska A, Deren-Wesolek A, Charakchieva-Minol S, Chojnacka-Wojcik E. Bioorg. Med. Chem. 1999; 7: 287.
7. Matecka D, Lewis D, Rothman RB, Dersch CM, Wojnicki FHE, Glowa JR, DeVries AC, Agu Pert, Rice KC. J. Med. Chem. 1997; 40: 705.
8. Sui Xiong Cai, Kher SM, Zhou Zhang-Lin, Ilyin V, Espitia SA, Tran M, Hawkinson JE, Woodward RM, Weber E, Keana JFW. J. Med. Chem. 1997; 40: 730.
9. Anticonvulsants. SmithKlineBeecham Pharmaceuticals: UK, 2000.
10. Segal I, Zablotskaya A, Lukevics E. Chem. Heterocycl. Compd 2005; 41: 613.
11. Zablotskaya A, Segal L Belykov S, Lukevics E. Appl. Organomet. Chem. 2006; 20: 149.
12. Lai Y-Y, Huang L-J, Lee K-H, Xiao Z, Bastow KF, Yamori T, Kuo S-C. Bioorg. Med. Chem. 2005; 13: 265.
13. Ferlin MJ, Gatto B, Chiarelotto G, Palumbo M. Bioorg. Med. Chem. 2001; 9: 1843.
14. Cagir A, Eisenhauer BM, Gao R, Thomas SJ, Hecht SM. Bioorg. Med. Chem. 2004; 12: 6287.
15. Deady LW, Desneves J, Kaye AJ, Finlay GJ, Baguley BC, Denny WA. Bioorg. Med. Chem. 2001; 9: 445.
16. Zablotskaya A, Segall, Germane S, Shestakoval, Lukevics E, Kniess T, Spies H. Appl. Organomet. Chem. 2002; 16: 550.
17. Ashgate Handbook of Antineoplastk Agents, Milne GWA (ed.). Gower: Aldershot, 2000.
18. Malonne H, Atassi G. Anticancer-Drugs 1997; 8: 811.
19. Spies H, Pietzsch HJ, Johannsen B. Technetium, Rhenium and other Metals in Chemistry and Nuclear Medicine, Vol. 5. SGEditoriali: Padova, 1999; 101.
20. Johnson NP, Lock CJ, Wilkinson L. Inorg. Synth. 1967; 9: 145.
21. Altomare A, Burla M, Camalli M, Cascarano G, Giacovazzo C, Guagliardi A, Moliterni A, Spagna R. J. Appl. Crystallogr. 1999; 32: 115.
22. Mackay S, Gilmore CJ, Edwards C, Stewart N, Shankland K. maXus Computer Program for the Solution and Refinement of Crystal Structures. Bruker Nonius, The Netherlands, MacScience, Japan & The University of Glasgow, 1999.
23. Freshney PJ. In Culture of Animal Cells (A Manual of Basic Technique). Wiley-Liss: New York, 1994; 296-297.
24. Fast DJ, Lynch RC, Leu RW. J. Leucocyt. Biol. 1992; 52: 255.
25. Mitsunobu O. Synthesis 1981; 1.
26. Corey EJ, Cimprich KA. Tetrahedron Lett. 1992; 33: 4099.